These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

432 related items for PubMed ID: 21599817

  • 1. Blood stream infections after allogeneic stem cell transplantation: a single-center experience with the use of levofloxacin prophylaxis.
    Busca A, Cavecchia I, Locatelli F, D'Ardia S, De Rosa FG, Marmont F, Ciccone G, Baldi I, Serra R, Gaido E, Falda M.
    Transpl Infect Dis; 2012 Feb; 14(1):40-8. PubMed ID: 21599817
    [Abstract] [Full Text] [Related]

  • 2. Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of Gram-negative rods and increasing antibiotic resistance.
    Mikulska M, Del Bono V, Raiola AM, Bruno B, Gualandi F, Occhini D, di Grazia C, Frassoni F, Bacigalupo A, Viscoli C.
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):47-53. PubMed ID: 19135942
    [Abstract] [Full Text] [Related]

  • 3. Bacterial and fungal bloodstream isolates from 796 hematopoietic stem cell transplant recipients between 1991 and 2000.
    Ortega M, Rovira M, Almela M, Marco F, de la Bellacasa JP, Martínez JA, Carreras E, Mensa J.
    Ann Hematol; 2005 Jan; 84(1):40-6. PubMed ID: 15480665
    [Abstract] [Full Text] [Related]

  • 4. Impact of bloodstream infections on outcome and the influence of prophylactic oral antibiotic regimens in allogeneic hematopoietic SCT recipients.
    Liu CY, Lai YC, Huang LJ, Yang YW, Chen TL, Hsiao LT, Liu JH, Gau JP, Chen PM, Tzeng CH, Chiou TJ.
    Bone Marrow Transplant; 2011 Sep; 46(9):1231-9. PubMed ID: 21113186
    [Abstract] [Full Text] [Related]

  • 5. Risk factors for pre- and post-engraftment bloodstream infections after allogeneic hematopoietic stem cell transplantation.
    Kikuchi M, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, Sakamoto K, Kawamura K, Ishihara Y, Sato M, Ashizawa M, Terasako-Saito K, Kimura S, Yamazaki R, Kanda J, Kako S, Nishida J, Kanda Y.
    Transpl Infect Dis; 2015 Feb; 17(1):56-65. PubMed ID: 25580541
    [Abstract] [Full Text] [Related]

  • 6. Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.
    Blennow O, Ljungman P, Sparrelid E, Mattsson J, Remberger M.
    Transpl Infect Dis; 2014 Feb; 16(1):106-14. PubMed ID: 24372809
    [Abstract] [Full Text] [Related]

  • 7. Enteric gram-negative bacilli bloodstream infections: 17 years' experience in a neonatal intensive care unit.
    Cordero L, Rau R, Taylor D, Ayers LW.
    Am J Infect Control; 2004 Jun; 32(4):189-95. PubMed ID: 15175611
    [Abstract] [Full Text] [Related]

  • 8. Bloodstream and central line isolates from hematopoietic stem cell transplant recipients: data from a developing country.
    Ali N, Adil SN, Shaikh MU.
    Transpl Infect Dis; 2014 Feb; 16(1):98-105. PubMed ID: 24383473
    [Abstract] [Full Text] [Related]

  • 9. Factors influencing the performance level of Candida mannan antigen testing in allogeneic stem cell transplant recipients not receiving fluconazole prophylaxis.
    Nihtinen A, Anttila VJ, Richardson M, Ruutu T, Juvonen E, Meri T, Volin L.
    Transpl Infect Dis; 2011 Jun; 13(3):266-72. PubMed ID: 21176021
    [Abstract] [Full Text] [Related]

  • 10. Fluoroquinolone resistance in hematopoietic stem cell transplant recipients with infectious complications.
    Bonadio M, Morelli G, Mori S, Riccioni R, Papineschi F, Petrini M.
    Biomed Pharmacother; 2005 Oct; 59(9):511-6. PubMed ID: 16274955
    [Abstract] [Full Text] [Related]

  • 11. Characteristics comparisons of bacteremia in allogeneic and autologous hematopoietic stem cell-transplant recipients with levofloxacin prophylaxis and influence on resistant bacteria emergence.
    Wang CH, Chang FY, Chao TY, Kao WY, Ho CL, Chen YC, Dai MS, Chang PY, Wu YY, Lin JC.
    J Microbiol Immunol Infect; 2018 Feb; 51(1):123-131. PubMed ID: 27103500
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The epidemiology of bacteremia with febrile neutropenia: experience from a single center, 1988-2004.
    Paul M, Gafter-Gvili A, Leibovici L, Bishara J, Levy I, Yaniv I, Shalit I, Samra Z, Pitlik S, Konigsberger H, Weinberger M.
    Isr Med Assoc J; 2007 Jun; 9(6):424-9. PubMed ID: 17642387
    [Abstract] [Full Text] [Related]

  • 17. Incidence of Febrile Neutropenia in Autologous Hematopoietic Stem Cell Transplant (HSCT) Recipients on levofloxacin prophylaxis.
    Signorelli J, Zimmer A, Liewer S, Shostrom VK, Freifeld A.
    Transpl Infect Dis; 2020 Apr; 22(2):e13225. PubMed ID: 31785022
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.